The urokinase receptor-derived cyclic peptide [SRSRY] suppresses neovascularization and intravasation of osteosarcoma and chondrosarcoma cells.
Ingangi V, Bifulco K, Yousif AM, Ragone C, Motti ML, Rea D, Minopoli M, Botti G, Scognamiglio G, Fazioli F, Gallo M, De Chiara A, Arra C, Grieco P, Carriero MV.
Ingangi V, et al. Among authors: motti ml.
Oncotarget. 2016 Aug 23;7(34):54474-54487. doi: 10.18632/oncotarget.9976.
Oncotarget. 2016.
PMID: 27323409
Free PMC article.